Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2288
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives ; volume:16 ; number:1 ; day:24 ; month:8 ; year:2016 ; pages:1-7 ; date:12.2016
BMC medical research methodology ; 16, Heft 1 (24.8.2016), 1-7, 12.2016
- Creator
-
Beckett, Robert D.
- Contributor
-
Loeser, Kathryn C.
Bowman, Kathryn R.
Towne, Trent G.
SpringerLink (Online service)
- DOI
-
10.1186/s12874-016-0215-2
- URN
-
urn:nbn:de:1111-2016092114527
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beckett, Robert D.
- Loeser, Kathryn C.
- Bowman, Kathryn R.
- Towne, Trent G.
- SpringerLink (Online service)
Other Objects (12)
Assessing transparency practices in dental randomized controlled trials
Code of Good Practices on Fiscal Transparency
Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
Intention-to-treat-Prinzip : Alternative Konzepte und Sensitivitätsanalysen in der Orthopädie
Number Needed to Treat in Multiple Sclerosis Clinical Trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
Transparency in reporting on anti-corruption : a report on corporate practices
Consensus Head Acceleration Measurement Practices (CHAMP): Origins, Methods, Transparency and Disclosure
Assessing transparency practices in dental randomized controlled trials
Code of Good Practices on Fiscal Transparency
Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
Intention-to-treat-Prinzip : Alternative Konzepte und Sensitivitätsanalysen in der Orthopädie
Number Needed to Treat in Multiple Sclerosis Clinical Trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
Transparency in reporting on anti-corruption : a report on corporate practices
Consensus Head Acceleration Measurement Practices (CHAMP): Origins, Methods, Transparency and Disclosure
Assessing transparency practices in dental randomized controlled trials
Code of Good Practices on Fiscal Transparency
Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
Intention-to-treat-Prinzip : Alternative Konzepte und Sensitivitätsanalysen in der Orthopädie
Number Needed to Treat in Multiple Sclerosis Clinical Trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Transparency and reporting characteristics of COVID-19 randomized controlled trials
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
Transparency in reporting on anti-corruption : a report on corporate practices